Visualitza per autor "Rutkowski, Piotr"
Ara mostrant els elements 1-3 d 3
-
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
Razak, Albiruni Abdul; Rosenbaum, E.; Jonczak, Emily; Hamacher, Rainer; Rutkowski, Piotr; Valverde Morales, Claudia Maria; HINDI, NADIA (Elsevier, 2023-12) -
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma
Bonvalot, Sylvie; Thariat, Juliette; Carrère, Sébastien; Ducassou, Anne; Sunyach, Marie-Pierre; Vergés Capdevila, Ramona; Rutkowski, Piotr (Elsevier, 2022-11-01) -
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers
Felip Font, Enriqueta; Morgensztern, Daniel; Trigo, José Manuel; Moreno, Victor; Curigliano, Giuseppe; Rutkowski, Piotr (Springer, 2022-04)